Wendy E. Wifler

Wendy E. Wifler is an experienced professional in the medical technology and healthcare industries, currently serving as Vice President of HEMA - Peripheral Interventions at Boston Scientific since July 2017. Wendy has held various leadership roles, including Vice President of Global Market Access at BTG and Vice President of U.S. Global Market Access at BTG plc prior to its acquisition by Boston Scientific. With a background in reimbursement strategy consulting at Verity Advisors Inc since 2010, Wendy has a strong focus on MedTech and clinical lab/molecular pathology. Additional experience includes serving on the AMA CPT CodeBridge™ Committee and strategic reimbursement roles at several healthcare companies. Wendy holds an Executive MBA with an entrepreneurial emphasis from Simmons College and a Bachelor of Science in Biological Sciences, along with a minor in Cognitive Psychology from UC Irvine.